Samphire Neuroscience, a medtech startup, has announced a successful $2.3 million pre-seed funding round for its pioneering neurotechnology wearable, Nettle. Designed to manage premenstrual syndrome (PMS) and menstrual pain, Nettle represents a significant step forward in at-home neurostimulation treatment. With over 90% of women affected by menstrual pain and PMS at some point, the demand for such solutions is evident. The funding…
The Essence App, focused on improving workplace environments for women and individuals with menstrual cycles, has completed a $600K funding round. Participants in the round include Berkeley SkyDeck Fund, Davidovs VC, Growing Well Partners, and notable angel investors like Eugenia Dunaeva and Ksenia Kapoor, among others. This financial boost aims to refine the app’s capabilities, broaden its customer base, and explore the…
Diva’Me, a femtech company co-founded by Prashant and Nadine Audi, has raised $1 million in pre-seed funding led by Verde. Based in Dubai, the company is committed to revolutionizing women’s health by advancing societal norms surrounding menstruation and offering innovative, technology-driven solutions. Central to Diva’Me’s mission is the development of an AI-based personalized counseling app. This forthcoming app is designed to connect…
Wow wow wow. We really started the year with a bit of a bang 💥 in women’s health last week: In a somewhat historic advancement for women’s health, Qvin’s received FDA approval of the Q-Pad, an innovative menstrual blood-based health monitoring pad. Qvin’s FDA approval last week was more then just a news story, it’s really a narrative shift, positioning menstrual blood at the very center…
Biotech research company Qvin has announced the FDA clearance of its innovative Q-Pad and A1c Test, marking a significant advancement in women’s health technology. This approval introduces a new method of health monitoring for millions of American women, particularly those living with diabetes, through menstrual blood testing. The Q-Pad offers a less invasive and more accessible alternative to traditional venous blood draws.…
Clue, a femtech and reproductive health platform, has recently announced a new initiative in collaboration with top global universities, including the University of California, Berkeley, and the University of Exeter, along with the Menarche Menstruation Menopause and Mental Health (4M) consortium. The initiative aims to use anonymized health data from Clue users to close the diagnosis gap for female health conditions. This…
At the Prototypes for Humanity 2023 event in Dubai, a project from Ghana, named “Plad,” has been presented, attracting attention for its unique approach to menstrual hygiene. This project, developed by students from Kwame Nkrumah University of Science and Technology, utilizes plantain pseudo-stems to create sustainable sanitary pads. The team behind Plad, consisting of Joshua Atta Alabi, Gabriella Selorm Gbekie, and Ebenezer…
Clue, a period tracking and reproductive health app and smart ring technology company ÅŒURA have announced a new integration. This partnership combines Clue’s menstrual health tracking with ÅŒURA’s biometric sensing capabilities, aiming to enhance personal health management and research in female health. The new integration allows iOS users of the Clue app to connect with the Oura Ring for tracking body temperature…